Gujarat Themis Biosyn (BOM:506879) EPS (Basic): ₹4.28 (TTM As of Mar. 2026)


BOM:506879 Gujarat Themis Biosyn Ltd BOM:506879
72 GF Score
Price ₹392.50
GF Value ₹312.79
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gujarat Themis Biosyn EPS (Basic)?

Gujarat Themis Biosyn BOM:506879 -2.28% 72 EPS (Basic) is ₹4.28 as of Mar. 2026. GuruFocus rates BOM:506879 with a GF Score™ of 72/100 and a GF Value™ of ₹312.79 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Gujarat Themis Biosyn's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹1.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.28.

Gujarat Themis Biosyn's EPS (Diluted) for the three months ended in Mar. 2026 was ₹1.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.28.

Gujarat Themis Biosyn's EPS without NRI for the three months ended in Mar. 2026 was ₹1.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 4.28.

During the past 12 months, Gujarat Themis Biosyn's average EPS without NRIGrowth Rate was -4.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -7.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 36.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Gujarat Themis Biosyn's highest 3-Year average EPS without NRI Growth Rate was 97.00% per year. The lowest was -22.90% per year. And the median was 11.70% per year.

Gujarat Themis Biosyn  (BOM:506879) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gujarat Themis Biosyn EPS (Basic) Related Terms

Gujarat Themis Biosyn EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Gujarat Themis Biosyn's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Themis Biosyn EPS (Basic) Chart

Gujarat Themis Biosyn Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 5.32 5.43 4.48 4.28

Gujarat Themis Biosyn Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 0.83 1.31 1.14 1.00
BOM:506879
72GF Score
Gujarat Themis Biosyn Ltd BOM:506879
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Themis Biosyn EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Gujarat Themis Biosyn's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(466.865-0)/109.081
=4.28

Gujarat Themis Biosyn's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(108.912-0)/108.912
=1.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹4.28 mean?
Gujarat Themis Biosyn (BOM:506879) has a EPS (Basic) of ₹4.28 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Gujarat Themis Biosyn and its competitors.
Is Gujarat Themis Biosyn's EPS (Basic) too high?
Gujarat Themis Biosyn's current EPS (Basic) is ₹4.28. Overall, Gujarat Themis Biosyn has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gujarat Themis Biosyn's EPS (Basic) compare to ZTS?
Gujarat Themis Biosyn's EPS (Basic) of ₹4.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Gujarat Themis Biosyn and its competitors. Gujarat Themis Biosyn's current EPS (Basic) is ₹4.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Themis Biosyn stock overvalued right now?
Based on GuruFocus' analysis, Gujarat Themis Biosyn (BOM:506879) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹312.79, compared to a current price of ₹392.50 — trading 25.5% above its estimated fair value. The current EPS (Basic) is ₹4.28. Gujarat Themis Biosyn's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Gujarat Themis Biosyn (BOM:506879), the current EPS (Basic) is ₹4.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gujarat Themis Biosyn (BOM:506879) Overvalued in 2026?

Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be overvalued. The current stock price of ₹392.50 is trading 25.5% above its estimated GF Value™ of ₹312.79. GuruFocus considers Gujarat Themis Biosyn to be Modestly Overvalued.

Key valuation signals for BOM:506879:

  • EPS (Basic): ₹4.28
  • GF Value™: ₹312.79 vs. price of ₹392.50 (25.5% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the BOM:506879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gujarat Themis Biosyn Business Description

Other Exchanges GUJTHEM:India
Address S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
72GF Score

Get the complete analysis for BOM:506879

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹392.50
Price
₹312.79
GF Value